Lineage Cell Therapeutics, Inc. (LCTX) ownership: Top institutional holder: BROADWOOD CAPITAL INC ($78.31M). Insider activity: Net Seller (2 buys, 8 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 49560992.00 | $78.31M | 2026-03-31 |
| VANGUARD GROUP INC | 9644276.00 | $16.11M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8318685.00 | $13.14M | 2026-03-31 |
| Defender Capital, LLC. | 6729599.00 | $10.63M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 5561374.00 | $8.79M | 2026-03-31 |
| RAFFLES ASSOCIATES LP | 5362788.00 | $8.47M | 2026-03-31 |
| COMERICA BANK | 4600000.00 | $7.68M | 2025-12-31 |
| FIFTH THIRD BANCORP | 4600000.00 | $7.27M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-12 | |
| Sell | null | 2026-03-05 | |
| Sell | null | 2026-03-05 | |
| Sell | null | 2026-03-05 | |
| Sell | null | 2026-02-11 | |
| Buy | null | 2026-02-11 | |
| Sell | null | 2026-02-11 | |
| Sell | null | 2026-02-11 |
Back to LCTX overview · LCTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.